Stryker reports slumping profits for the 4th quarter and all of 2014, blaming in part the recalls of its Rejuvenate and ABG II hip implants and Neptune waste management device.
Stryker (NYSE:SYK) today reported slumping profits for the 4th quarter and all of 2014, missing earnings expectations by a penny after the cost of several recalls suppressed the bottom line.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tmjUab
Cap comentari:
Publica un comentari a l'entrada